Boehringer Ingelheim consistently continues growth phase in financial year 2012
24 April 2013 | By Boehringer Ingelheim
Net sales rose by 11.5 percent to around €14.7 billion...
List view / Grid view
News
Merck to present updated interim data from Phase II trial
23 April 2013 | By Merck
Merck announced the presentation of the latest interim data from a Phase II, multi-center, randomized, dose-ranging clinical trial...
Teva and Xenon announce FDA orphan drug designation for pain drug XEN402
23 April 2013 | By TEVA
"We are very pleased to receive orphan drug designation for XEN402..."
Data from Phase 3 studies of Gilead’s sofosbuvir for hepatitis C to be presented at 48th Annual EASL Meeting
23 April 2013 | By Gilead Sciences
Detailed results from four Phase 3 clinical trials...
Alchemia announces multi-target drug discovery collaboration with AstraZeneca on VAST discovery platform
23 April 2013 | By Alchemia Limited
Alchemia has signed a multi-target, drug discovery collaboration with AstraZeneca...
Boehringer Ingelheim announces results from one of its HCV Phase III trials
23 April 2013 | By Boehringer Ingelheim
Results from the pivotal Phase III STARTVerso™1 trial...
Novartis once-daily QVA149 shows superior efficacy in reducing exacerbations, improving lung function and quality of life in COPD patients
23 April 2013 | By Novartis
Results from the 64-week SPARK study...
Roche to change Applied Science business structure
23 April 2013 | By Roche
Measures aim to ensure sustained success in a fast-changing market environment...
Amgen welcomes European Commission report on EU biosimilars uptake
22 April 2013 | By Amgen
Amgen welcomes a new report from the European Commission...
Lundbeck introduces Selincro® as the first and only medicine for the reduction of alcohol consumption in alcohol dependent patients
22 April 2013 | By H. Lundbeck A/S
Lundbeck launches Selincro®...
Daiichi Sankyo launches silodosin for the treatment of dysuria in China
22 April 2013 | By Daiichi Sankyo
Daiichi Sankyo announced that its subsidiary, Daiichi Sankyo Pharmaceutical (Beijing) Co., Ltd., has begun marketing silodosin...
Hexyon/Hexacima 6-in-1 pediatric vaccine approved in Europe
22 April 2013 | By Sanofi Pasteur
Hexyon/Hexacima is the only fully liquid, ready-to-use, 6-in-1 pediatric vaccine...
GSK and Theravance announce regulatory submission for ANORO™ ELLIPTA™ in Japan
22 April 2013 | By GlaxoSmithKline
Submission of a regulatory application to the Japanese MHLW...
AstraZeneca and BIND Therapeutics announce worldwide development and commercialisation agreement for cancer nanomedicine
22 April 2013 | By AstraZeneca
“We are excited to grow this collaboration..."
Merck enters agreement with Bristol-Myers Squibb
22 April 2013 | By Merck
Agreement to conduct a Phase II clinical trial evaluating combination of investigational oral candidates MK-5172 and daclatasvir for chronic hepatitis C...
